Dr. Axe Wire · Study decoded · health
Weighted ApoB Score Tracks Coronary Risk Across Ethnic Groups
A modified apoB formula that accounts for triglycerides and lipoprotein(a) tracked coronary events more closely than standard apoB testing.
A reworked version of the apoB cholesterol test, called risk-weighted apoB, tracked coronary events more closely than standard apoB testing, in a study of 40,132 adults published October 17, 2026 in the European Journal of Preventive Cardiology.
Researchers pooled data from 40,132 adults with 4,509 coronary events across five long-running studies: ARIC, CARDIA, MESA, the Framingham Offspring Study and China Kadoorie Biobank. They calculated a risk-weighted apoB score that adds in triglyceride-carrying particles and lipoprotein(a), a sticky, inherited fat particle, then compared how well it tracked coronary events against standard apoB measurements alone.
The weighted score was linked to coronary events beyond what standard apoB explained in White, African American, Chinese and Hispanic participants, with risk rising 11%, 11%, 8% and 10% per 10 mg/dL increase, respectively. Average risk-weighted apoB ran about 8 mg/dL higher than standard apoB in African American participants, reflecting higher lipoprotein(a), and in Chinese participants, reflecting higher triglycerides. A statistical measure of how well each score predicted events improved from 0.617 to 0.630 in White participants and from 0.554 to 0.567 in Chinese participants; gains in African American and Hispanic groups were smaller and not statistically confirmed.
Standard apoB counts every cholesterol-carrying particle in the blood, since artery damage tracks more closely with the number of particles than with how much cholesterol each one carries. More broadly, triglyceride-rich particles and lipoprotein(a) are both known to behave differently in the bloodstream depending on genetics and ethnic background; this study did not test why that happens, only that counting them separately tracked coronary events more closely in some groups.
Higher Coronary Risk per 10 mg/dL Increase in Risk-Weighted ApoB
This was an observational analysis of existing cohort data, which shows a link rather than proof that the weighted score itself changes outcomes. The prediction improvement reached statistical confirmation mainly in the larger White and Chinese groups, so the same gain in African American and Hispanic participants is not yet established.
Dr. Axe’s Take
Counting particles beats counting cholesterol cargo, and this study adds a useful layer: not all particles carry equal weight. Triglyceride-rich particles and lipoprotein(a) tracked extra risk that a standard apoB count missed in some groups. My view is this strengthens the case for asking about a fuller lipoprotein picture, not just LDL, when you're assessing heart risk. This week, I'd focus on foods that lower triglycerides directly, cutting refined sugar and alcohol, adding fatty fish and fiber-rich vegetables, and ask your doctor whether a lipoprotein(a) measurement makes sense alongside your standard panel.
— Dr. AxeStudy summary
- Who
- 40,132 adults with 4,509 coronary events from ARIC, CARDIA, MESA, Framingham Offspring Study, China Kadoorie Biobank
- Design
- Meta-analysis of five pooled cohort studies with Cox regression and random-effects pooling by ethnic group
- Dose
- Not applicable; risk-weighted apoB calculated from triglyceride and lipoprotein(a) levels using a prespecified equation
- Primary result
- Risk-weighted apoB linked to coronary events beyond standard apoB: 11% higher risk per 10 mg/dL in White, 11% in African American, 8% in Chinese, 10% in Hispanic participants
- Secondary
- Prediction accuracy rose from 0.617 to 0.630 in White and 0.554 to 0.567 in Chinese participants; gains in African American and Hispanic groups not statistically confirmed
- Funding / conflicts
- Funders listed in the journal record: Swedish Research Council; Swedish Heart Lung Foundation; Swedish government and the county councils. Conflicts not reported in the abstract.
- Date
- Oct 17, 2026



